SAN FRANCISCO (AP) _ Twist Bioscience Corp. (TWST) on Tuesday reported a loss of $25.9 million in its fiscal second quarter.
The San Francisco-based company said it had a loss of 93 cents per share.
The maker of synthetic DNA for the biotechnology industry posted revenue of $13.6 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $11.9 million.
Twist Bioscience expects full-year revenue in the range of $50 million to $52 million.
Twist Bioscience shares have risen slightly more than 2% since the beginning of the year.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TWST at https://www.zacks.com/ap/TWST